| 000 | 01669 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514213828.0 | ||
| 264 | 0 | _c20050412 | |
| 008 | 200504s 0 0 eng d | ||
| 022 | _a0169-5002 | ||
| 024 | 7 |
_a10.1016/j.lungcan.2004.08.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFennell, Dean A | |
| 245 | 0 | 0 |
_aPhase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma. _h[electronic resource] |
| 260 |
_bLung cancer (Amsterdam, Netherlands) _cFeb 2005 |
||
| 300 |
_a277-81 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMesothelioma _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aOxaliplatin |
| 650 | 0 | 4 |
_aPleural Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVinblastine _xadministration & dosage |
| 650 | 0 | 4 | _aVinorelbine |
| 700 | 1 | _aC Steele, Jeremy P | |
| 700 | 1 | _aShamash, Jonathan | |
| 700 | 1 | _aSheaff, Michael T | |
| 700 | 1 | _aEvans, Marie T | |
| 700 | 1 | _aGoonewardene, Tyronne I | |
| 700 | 1 | _aNystrom, Maria L | |
| 700 | 1 | _aGower, N H | |
| 700 | 1 | _aRudd, Robin M | |
| 773 | 0 |
_tLung cancer (Amsterdam, Netherlands) _gvol. 47 _gno. 2 _gp. 277-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.lungcan.2004.08.005 _zAvailable from publisher's website |
| 999 |
_c15319523 _d15319523 |
||